Advances in Gastroenterology, 2007
An Internet-based CME Activity
Release date: January 15, 2007, Expiration date: January 15, 2009
Dr. Joel Richter is the chair for Recent Advances in Gastroenterology.
The program series entails the discussion of six different topics
in Gastroenterology such as Inflammatory Bowel disease, Gastroesophageal
Reflux Disease, Irritable Bowel Syndrome, Peptic Ulcer Disease,
and Hepatitis C and Nonalcoholic Fatty Liver Disease.
|
|
 |
This on-line multimedia activity has been planned
and produced in accordance with the ACCME Essential Areas and
Policies.
This program is supported by unrestricted education grants
from AstraZeneca and Schering Plough.
Intended Audience
This program is intended for primary care physicians, family practitioners,
gastroenterologists, internists, nurse practitioners, and physician
assistants.
Accreditation
Temple University School of Medicine is accredited by the
Accreditation Council for Continuing Medical Education (ACCME)
to sponsor Continuing Medical Education for Physicians.
This activity has been planned and produced in accordance with
the ACCME Essential Areas and Policies.
Certification Statement: Information on CME Credit
Temple University School of Medicine designates this educational
activity for a maximum of 5.75 AMA Physician's Recognition Award
Category 1 Credit(s). Physicians should only claim credit commensurate
with the extent of their participation in the activity.
Instructions for CME credit
It is estimated that it will require 1 hour per activity to review
the material in this continuing medical education program and answer
the self-assessment questions. After completing this program, answer
the self-assessment and program evaluation questions using the
online form. You will be able to print your CME certificate online.
|
|
|
Disclosure of Significant Relationships
With Relevant Commercial Companies/Organizations
Disclosure Policy
It is the policy of Temple University School of Medicine, The Albert J.
Finestone, M.D. Office for Continuing Medical Education to insure balance,
independence, objectivity and scientific rigor in all of it's sponsored
or jointly sponsored educational programs. All faculty participating in
programs sponsored or jointly sponsored by Temple University School of
Medicine are expected to disclose to the program audience any real or apparent
conflict (s) of interest related to the content of their presentation(s).
The information presented at this CME program represents the views and
opinions of the individual presenters, and does not constitute the opinion
or endorsement of, or promotion by, Temple University School of Medicine,
Temple University Health System or its affiliates. Reasonable efforts have
been taken intending for educational subject matter to be presented in
a balanced, unbiased fashion and in compliance with regulatory requirements.
However, each program attendee must always use his/her own personal and
professional judgment when considering further application of this information,
particularly as it may relate to patient diagnostic or treatment decisions
including, without limitation, FDA-approved uses and any off-label uses.
Faculty Disclosures
It is the policy of Temple University School of Medicine, Office for Continuing
Medical Education to insure balance, independence, objectivity, and scientific
rigor in all its individually sponsored educational programs. All faculty
participating in any Temple University sponsored programs are expected
to disclose to the program audience ANY real or apparent conflict(s) of
interest that may have a direct bearing on the subject matter of the continuing
education program. This pertains to relationships with pharmaceutical companies,
biomedical device manufacturers, or other corporations whose products or
services are related to the subject matter of the presentation topic. The
intent of this policy is that any potential conflict should be identified
openly so that the listeners may form their own judgments about the presentation
with the full disclosure of the facts. ALL faculty for Recent Advances
in Gastroenterology have provided disclosure information. Listed below
are those faculty who have indicated a relationship with a commercial company.
Such disclosure should not be construed as a conflict of interest, but,
rather as a disclosure of a current or previous financial arrangement.
All other faculty have indicated they do not have a financial relationship
to disclose. Temple University School of Medicine assures independence
and balance of content by resolving current conflicts of interest by reviewing
all speaker's powerpoint slides prior to their presentation to ensure that
the content is based on a structured review for the best scientific evidence
at the time of the presentation.
Bruce R. Bacon, MD: Schering Plough, Roche Laboratories, Gilead
Sciences, Bristol-Myers Squibb, Glaxo Smith Kline, Coley Pharmaceuticals,
Axcan Pharma, Bayer Diagnostics, Genetrol Biotherapeutics, Serono International,
Novartis, ISIS, NIH, Intermune, Resonance Health, Valeant.
William D. Chey, MD: Janssen, Novartis, Promethius, Sanofi, TAP,
Sucampo, AGI, Allergan, Glaxo Smith Kline, ESA, Novartis, Proctor and Gamble,
Microbia, Salix, Smart Pill, Takeda, Tap Santarus.
Brett Lashner, MD: Shire, Proctor and Gamble, Abbott, Prometheus,
UCB, Elan.
Emeran A. Mayer, MD: Glaxo Smith Kline, Novartis, Danone
Joel E. Richter, MD: AstraZeneca, TAP, Medtronic
Hardware/Software Requirements
The web-based CME activity requires a version 4.x web browser or newer
and is best experienced using a current generation browser such as Internet
Explorer 5.5/6.0 or newer. The presentation component is designed for 800x600
screen resolution or better. The presentation component is available in
multiple formats to accommodate various system configurations and capabilities
and includes a for-print version requiring Adobe Acrobat Reader, and an
audio narrated version requiring Macromedia Flash Player 7.0. CMEPipeline.com
requires that JavaScript and cookies be enabled to control the presentation
(for more information about how cookies are used by this site, refer to
the CMEPipeline.com privacy and ethics
policy).
More information about the software described above is available by following
the links below:
Rievent Technologies provides technical support for the CMEPipeline.com
web site and is available to assist you with questions related
to technical requirements for participating in the web-based program.
Technical support for CMEPipeline.com is available via the support form.
Privacy and Information Use
Rievent Technologies, the operator of this site, is committed
to protecting your privacy and following pharmaceutical industry
best practices and regulations regarding continuing medical education.
For information about CMEPipeline.com privacy and information
use, refer to the CMEPipeline.com
privacy and ethics statement.
Contact Us
Rievent Technologies and CMEPipeline.com may be contacted using
the support link at the top of this page.
Questions about the content of this CME Program should be addressed
to:
Melinda Somasekhar, Ph.D., Director of CME
Temple University School of Medicine, Albert J. Finestone Office of CME
somasem@temple.edu
http://www.temple.edu/medicine/cme/
Content copyrighted © 2006 Temple University School of Medicine.
|
